Results 51 to 60 of about 14,212,615 (258)

Rapid Assessment of Vascular Exit Site and Tunneling Options (RAVESTO): A new decision tool in the management of the complex vascular access patients

open access: yes, 2021
In the last decade, different standardized protocols have been developed for a systematic ultrasound venous assessment before central venous catheterization: RaCeVA (Rapid Central Vein Assessment), RaPeVA (Rapid Peripheral Vein Assessment), and RaFeVA ...
Ostroff, MD, Pittiruti, M, Moureau, N
core   +1 more source

Vascular access in children

open access: yesIndian Journal of Anaesthesia, 2019
Securing stable vascular access is an important clinical skill for the anaesthesiologist. Sick children, complex surgeries, chronic illnesses, multiple hospitalisations, and prolonged treatments can make vascular access challenging.
Vibhavari M Naik   +2 more
doaj   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

open access: yesFEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta   +3 more
wiley   +1 more source

Vascular Access by Specialists

open access: yes, 2020
Achieving reliable vascular access (VA) for children devoid of pain, anxiety, and complication is the goal of pediatric VA specialists. VA prevails across various settings, both inpatient and outpatient.
Pitts, Stephanie   +3 more
core   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Reality check: primary vascular access creation today. [PDF]

open access: yes, 2018
INTRODUCTION In Switzerland, the outcome of vascular access creation in the 4500 current dialysis patients is unknown, mainly because there is no prospective registry for patients undergoing vascular access surgery for renal replacement therapy.
Gahl, Brigitta   +11 more
core   +2 more sources

Better patency, lower rate of infection and steal syndrome in HD-vascular access grafts made using biological or semi-biological materials

open access: yes, 2008
Better patency, lower rate of infection and of steal syndrome in HD-vascular access grafts made using biological /semi-biological materials. Berardinelli ,Beretta, Raiteri.
C. Beretta, M. Raiteri, L. Berardinelli
core   +2 more sources

Liver organoids: modelling complexity in homeostasis and disease

open access: yesFEBS Letters, EarlyView.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

The MIDLINE trial – managing intravenous devices among patients with limited vascular access or prolonged therapy: a pilot randomised control trial protocol

open access: yes, 2020
Introduction Peripheral intravenous catheters (PIVCs) are essential for administration of intravenous fluids and medications. While patient need for PIVCs is high, up to 69% fail due to complications such as occlusion and infiltration. Midline catheters (
Marsh, Nicole   +7 more
core   +1 more source

Defining priorities in vascular access research

open access: yes, 2022
Introduction: There is increasing need for renal replacement therapy associated with the aging population and dramatic increases in diabetes prevalence.
Gronlund, T   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy